Pages that link to "Q39490838"
Jump to navigation
Jump to search
The following pages link to Cabozantinib as a novel therapy for renal cell carcinoma (Q39490838):
Displaying 21 items.
- The Receptor Tyrosine Kinase AXL in Cancer Progression (Q28068756) (← links)
- Clinical use of cabozantinib in the treatment of advanced kidney cancer: efficacy, safety, and patient selection (Q28074834) (← links)
- Microenvironment, oncoantigens, and antitumor vaccination: lessons learned from BALB-neuT mice (Q33786788) (← links)
- DCLK1 is correlated with MET and ERK5 expression, and associated with prognosis in malignant pleural mesothelioma (Q33788066) (← links)
- Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer Therapy (Q33859472) (← links)
- Safety and activity of temsirolimus and bevacizumab in patients with advanced renal cell carcinoma previously treated with tyrosine kinase inhibitors: a phase 2 consortium study (Q35144490) (← links)
- Development of a realistic in vivo bone metastasis model of human renal cell carcinoma (Q35154534) (← links)
- Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer (Q36436763) (← links)
- MET abnormalities in patients with genitourinary malignancies and outcomes with c-MET inhibitors (Q37485001) (← links)
- Factors involved in treatment preference in patients with renal cancer: pazopanib versus sunitinib (Q37729723) (← links)
- Targeting angiogenesis in renal cell carcinoma (Q38132231) (← links)
- New agents in renal cell carcinoma (Q38163483) (← links)
- Update in systemic therapy of urologic malignancies. (Q38176143) (← links)
- Does a reasonable treatment approach beyond second-line exist? (Q38555875) (← links)
- Emerging therapeutic approaches in renal cell carcinoma (Q38587958) (← links)
- Cabozantinib for the treatment of kidney cancer (Q38668871) (← links)
- Modulating the function of ATP-binding cassette subfamily G member 2 (ABCG2) with inhibitor cabozantinib (Q38718947) (← links)
- Cabozantinib for Renal Cell Carcinoma: Current and Future Paradigms. (Q38746778) (← links)
- Renal cancer. (Q50941188) (← links)
- Stomatitis and VEGFR-Tyrosine Kinase Inhibitors (VR-TKIs): A Review of Current Literature in 4369 Patients. (Q55476332) (← links)
- An update on current management of advanced renal cell cancer, biomarkers, and future directions (Q56897121) (← links)